From the American Academy of Ophthalmology

This prospective study included 30 newly diagnosed patients started on travoprost eye drops and randomized to morning or evening administration for one month and then switched to the opposite dosing schedule for another month. Adherence to morning dosing was 90.9 percent and adherence to evening dosing was 87.3 percent. Men were more adherent to morning dosing than evening dosing (P = .039). Adherence among women was similar in the morning and evening. Overall adherence was 91.7 percent in the first month and 86.5 percent in the second month. A majority of patients expressed a preference for morning dosing. Glaucoma, January 2013